- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03254953
GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss
GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss: Does Developing Mastery Before Tracking Diet Enhance Engagement?
This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email.
The investigators hypothesize that the group that delays diet tracking and receives additional intervention components (weekly personalized feedback, skills training, and action plans) will have greater weight loss at the end of the 12-week intervention and at 6-month followup, compared to (a) an intervention group that simultaneously tracks weight and diet for all 12 weeks and receives the same additional components, and (b) a control group that tracks only diet.
Study Overview
Status
Conditions
Detailed Description
This study will examine whether a digital health intervention (GoalTracker) can promote weight loss among adults who are overweight or obese. Engagement in self-monitoring often declines over time, which is then associated with suboptimal weight loss. Finding ways to improve self-monitoring engagement, particularly in the first month of treatment, is needed. Promoting mastery, self-efficacy, and self-regulatory skills may help with maintaining high engagement.
The investigators aim to enroll 105 participants. All groups are asked to self-monitor daily on their smartphone using the free commercial mobile application MyFitnessPal over the course of the 12-week intervention.
Specifically, the study aims to...
- Determine the effect of a Sequential self-monitoring intervention, compared to a Simultaneous self-monitoring intervention on weight change, caloric intake change, and proportion of individuals achieving 5% weight loss.
- Determine the effect of the Sequential self-monitoring intervention, compared to the Control, on the same variables.
- Compare self-monitoring engagement by intervention arm.
- Examine the relation between self-monitoring engagement and weight loss.
- Investigate theoretical mediators (self-efficacy, mastery, and self-regulation) on the relation between treatment arm and weight change.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ages 21-65 years old
- Body Mass Index (BMI) 25-45 kg/m2
- interested in losing weight through dietary change
- current use of iPhone or Android smartphone
- current use of email address
- has daily access to a bathroom scale
- no recent weight loss (≥10 lbs) in the past 6 months
- able to read and write in English
- able to attend 3 in-person evaluation visits at Duke University in Durham, North Carolina over a 3-month period
Exclusion Criteria:
- current participation in another weight loss treatment
- currently pregnant or planning to become pregnant within study period, or < 1 year post-partum
- history of cardiovascular event, eating disorder, diabetes mellitus, hypothyroidism, cancer, end stage renal disease
- current uncontrolled hypertension
- use of the MyFitnessPal app to track food in the past 6 months
- Former or planned bariatric surgery
- current use of medication (e.g., lithium, steroids, anti-psychotics)
- use of weight loss medication in past 6 months
- profound cognitive, developmental, or psychiatric disorders or recent hospitalization in a psychiatric facility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sequential Intervention
|
- weigh daily for 3 months and track their weight using the MyFitnessPal mobile app
- these are additional evidence-based intervention components
|
|
Experimental: Simultaneous Intervention
|
- weigh daily for 3 months and track their weight using the MyFitnessPal mobile app
- these are additional evidence-based intervention components
|
|
Experimental: Control (diet-tracking only)
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Weight
Time Frame: Baseline, 1 month, 3 months
|
Weight will be collected in kilograms using a calibrated digital scale
|
Baseline, 1 month, 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Individuals Achieving ≥ 5% Weight Loss
Time Frame: Baseline to 3 months
|
Weight will be collected in kilograms using a calibrated digital scale
|
Baseline to 3 months
|
|
Change in Caloric Intake
Time Frame: Baseline, 3 months
|
Caloric intake will will be assessed using the Automated Self-Administered 24-hour Dietary Intake Assessment (ASA24), an online dietary recall tool developed by the National Cancer Institute
|
Baseline, 3 months
|
|
Change in Weight at 6 Months
Time Frame: 6 months
|
At 6-months (i.e., 3 months post-intervention), self-reported weight will be collected
|
6 months
|
|
Self-Monitoring Engagement
Time Frame: Baseline to 1-month and 3 months
|
Frequency of self-monitoring weight and diet; Consistency of self-monitoring weight and diet
|
Baseline to 1-month and 3 months
|
|
Self-Efficacy
Time Frame: Baseline, 1 month, 3 months
|
Weight Efficacy Lifestyle Questionnaire (WEL) (20 items) will assess self-efficacy for eating.
Separate surveys that were adapted will assess self-efficacy for self-monitoring of diet and weight.
|
Baseline, 1 month, 3 months
|
|
Mastery
Time Frame: Baseline, 1 month, 3 months
|
The Automaticity subscale of The Self-Report Habit Index (SRHI) will assess mastery of self-monitoring diet and weight (4 items each).
|
Baseline, 1 month, 3 months
|
|
Self-Regulation
Time Frame: Baseline, 1 month, 3 months
|
The Three Factor Eating Questionnaire-R18 (TFEQ-R18) (18 items) will assess self-regulation for controlled eating.
Separate surveys that were adapted will assess self-regulation for self-monitoring of diet and weight.
|
Baseline, 1 month, 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: Baseline, 3 months
|
Paffenbarger Activity Questionnaire (7 items) will assess physical activity.
|
Baseline, 3 months
|
|
Sleep Quality
Time Frame: Baseline, 1 month, 3 months
|
Medical Outcomes Study (MOS) Sleep (12 items) will assess sleep quality.
|
Baseline, 1 month, 3 months
|
|
Perceived Stress
Time Frame: Baseline, 3 months
|
Perceived Stress Scale (10 items)
|
Baseline, 3 months
|
|
Depressive Symptoms
Time Frame: Baseline, 1 month, 3 months
|
Patient Health Questionnaire (PHQ-8) will assess depressive symptoms.
|
Baseline, 1 month, 3 months
|
|
Health-Related Quality of Life
Time Frame: Baseline, 1 month, 3 months
|
EuroQol-5 Dimension (EQ-5D) (5 items) will assess health-related quality of life.
|
Baseline, 1 month, 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michele G Lanpher, MA, Duke University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D0822
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on self-monitoring of body weight
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity & OverweightUnited States
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Overweight | Weight Loss | Health BehaviorUnited States
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI); Duke UniversityCompleted
-
Stanford UniversityNot yet recruitingObesity | Overweight | Weight Loss | Health Behavior | Lifestyle InterventionUnited States
-
International Centre for Diarrhoeal Disease Research...Bill and Melinda Gates Foundation; Salu Design GroupRecruitingHypertension, Pregnancy-Induced | Hypertension in Pregnancy | Hypertension, Essential Hypertension | Hypertension; Pre-EclampsiaBangladesh
-
Chang Hee, LeePurdue University; LG Electronics Inc.CompletedObesity | Metabolic SyndromeKorea, Republic of
-
Universidade Federal de Sao CarlosFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...CompletedVascular Accident, Brain | Cerebrovascular Accident | Cerebrovascular Stroke
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Wake Forest University Health SciencesTerminatedSepsis | Obesity | Septic ShockUnited States
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityWithdrawnBronchopulmonary Dysplasia | PretermChina